Skip to content

Precision treatment of cardiogenic shock guided by an artificial intelligence model based on hemodynamic monitoring

Precision treatment of cardiogenic shock guided by an artificial intelligence model based on hemodynamic monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080677
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiogenic shock

Interventions

PiCCO group:Monitor hemodynamic parameters, integrate demographic information, medical history, clinical presentation, laboratory test results, quantitative imaging parameters, etc. to create an artif
Control group:Determine the treatment plan based on the clinical experience of the attending physician

Sponsors

Shanghai East Hospital (East Hospital Affiliated To Tongji University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Age=18 years old, male or non-pregnant female; ? Signed the informed consent; ? Diagnosed with cardiogenic shock.

Exclusion criteria

Exclusion criteria: ? Extensive peripheral vascular disease; ? Severe heart valve disease; ? Patient treated with ECMO or Impella; ? Pregnant or lactating women; ? Participation in other clinical studies; ? Lack of informed consent or non-compliance with follow-up requirements.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events, including all-cause death, cardiac death, and unplanned readmission for heart failure);

Secondary

MeasureTime frame
Length and cost of hospitalization;Duration of instrument-assisted treatment during hospitalization, including mechanical ventilation and continuous renal replacement therapy;Duration of inotropes, diuretics, vasopressors, or vasodilators during hospitalization;Changes of parameters related to cardiac function, including NT-proBNP, LVEF, Scr, ALT, Lac, CMR, 6MWT, CPET, Minnesota Heart Failure Quality of Life Scale, etc.;Complications such as hemorrhage, hematoma, embolism and infection;

Countries

China

Contacts

Public ContactJieyun You

Shanghai East Hospital (East Hospital Affiliated To Tongji University)

youjieyun1118@hotmail.com+86 139 1779 1748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026